Already a DIA Member? Sign in. Not a member? Join.

Sign in

Forgot User ID? or Forgot Password?

Not a Member?

Create Account and Join

Virtual Event

Jun 14, 2020 9:00 AM - Jun 18, 2020 5:00 PM

(Eastern Standard Time)

Fort Washington, PA 19034

DIA 2020 Global Annual Meeting

Next Generation Analytics: Harnessing the Power of Nonclinical SEND Datasets to Improve Success in Early Clinical Development

Session Chair(s)

Todd  Page, PhD

Todd Page, PhD

Director, Toxicology

Eli Lilly and Company, United States

The nonclinical SEND data standard represents a tremendous opportunity to enable large-scale data analytic approaches for nonclinical data, but further harmonization of SEND compliant data is necessary. The panel discussion will discuss both the opportunity represented by SEND, the further harmonization needed to realize this opportunity, and potential solutions to address the current gaps in data harmonization.

Learning Objective : Recognize the opportunity that SEND compliant datasets represent to enable the implementation of large-scale, robust analytic approaches to assess pre-clinical data; Identify the current challenges of performing cross-study analysis using SEND compliant nonclinical data; Discuss solutions that will address the challenges with cross-study analysis to enable large-scale analytics.

Speaker(s)

Kevin  Snyder, PhD

Novel Opportunities and Technical Challenges Utilizing SEND Compliant Nonclinical Data

Kevin Snyder, PhD

FDA, United States

Computational Pharmacologist, OND, CDER

Todd  Page, PhD

Cross-Study Analysis: Lessons Learnied From Collaboration

Todd Page, PhD

Eli Lilly and Company, United States

Director, Toxicology

Susan  DeHaven, MSc

Panelist

Susan DeHaven, MSc

Sanofi, United States

Director, Data Standards and Business Applications

Debra  Oetzman

Panelist

Debra Oetzman

Instem LSS Ltd., United States

Senior Information Scientist, Data Standards Lead

Have an account?

Be informed and stay engaged.

Don't miss an opportunity - join our mailing list to stay up to date on DIA insights and events.